Our study identifies EIF4A3 as a critical post-transcriptional regulator and downstream effector of the TGF-β/SMAD pathway. EIF4A3 forms a positive feedback loop with TGF-β/SMAD signaling, thereby reinforcing EMT and promoting metastatic progression in GC. These findings establish EIF4A3 as a novel post-transcriptional amplifier of TGF-β signaling and a promising candidate for diagnostic and therapeutic intervention in metastatic GC.
Building similarity graph...
Analyzing shared references across papers
Loading...
Yujing Liu
Yanhua Zhang
Wenhuan Dou
Cell Biology and Toxicology
Soochow University
Second Affiliated Hospital of Soochow University
China Academy of Chinese Medical Sciences
Building similarity graph...
Analyzing shared references across papers
Loading...
Liu et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69dc87ea3afacbeac03ea07b — DOI: https://doi.org/10.1007/s10565-026-10171-6
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: